FDA: Patients Can Get Paxlovid, Lagevrio Even With Negative COVID Test

Story Updated Patients no longer need to test positive for COVID-19 in order to receive a prescription for Pfizer’s Paxlovid and Merck’s Lagevrio, FDA announced Wednesday (Feb. 1) , less than a week after the agency announced that another COVID-19 drug, AstraZeneca's Evusheld, is not currently authorized for use in the United States until further notice by FDA. FDA recognizes that in rare instances, people who have been recently exposed to and develop signs and symptoms consistent...